UROLIFT SYSTEM FOR BPH TREATMENT NOT PROVIDED BY MD NOT PROVIDED

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2019-05-20 for UROLIFT SYSTEM FOR BPH TREATMENT NOT PROVIDED BY MD NOT PROVIDED manufactured by Neotract Inc..

Event Text Entries

[145784111] Urolift implants were placed in through urinary tract. Was told removed same way. Md informed me he has never reversed procedure and must be surgically removed. Became immediately chronic. Infected and hospitalized to save life. Painful device prevents use of numerous prescribed meds, and otc product can't use many antibiotic meds to fight infection and feel product and / or removal would be life threatening. Fda safety report id# (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5086783
MDR Report Key8627780
Date Received2019-05-20
Date of Report2019-05-16
Date of Event2017-12-29
Date Added to Maude2019-05-21
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationPATIENT
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameUROLIFT SYSTEM FOR BPH TREATMENT
Generic NameIMPLANTABLE, TRANSPROSTATIC TISSUE RETRACTOR SYSTEM
Product CodePEW
Date Received2019-05-20
Model NumberNOT PROVIDED BY MD
Catalog NumberNOT PROVIDED
Lot NumberNOT PROVIDED
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerNEOTRACT INC.
Manufacturer AddressPLEASANTON CA US


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Life Threatening; 3. Other 2019-05-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.